May 14, 2018 / 8:13 PM / 10 days ago

BRIEF-Sophiris Bio Reports Q1 Loss Per Share $0.11

May 14 (Reuters) - Sophiris Bio Inc:

* SOPHIRIS BIO REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND KEY CORPORATE HIGHLIGHTS

* Q1 LOSS PER SHARE $0.11

* SOPHIRIS BIO - EXPECTS CASH AND CASH EQUIVALENTS WILL BE SUFFICIENT TO FUND OPERATIONS TO MIDDLE OF 2019, ASSUMING NO NEW CLINICAL TRIALS ARE INITIATED

* AT MARCH 31, 2018, CO HAD CASH, CASH EQUIVALENTS AND SECURITIES AVAILABLE-FOR-SALE OF $22.1 MILLION AND WORKING CAPITAL OF $19.2 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below